BIBLIOGRAPHY
This new section of the site is dedicated to articles related to cefprozil, and provides detailed and analytical information for professional use.
These scientific documents focus primarily on its use, and cover specific areas such as medical studies, the latest clinical research and new advances taking place within the pharmaceutical industry.
If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.
[Antibiotic susceptibility and molecular mechanisms of cephalosporins resistance in Klebsiella isolates from patients with hospital-acquired infections]
Antibiot Khimioter 2006 ;51(11-12):29-36
Impact of Empiric Antibiotic Use on Development of Infections caused by Extended-Spectrum beta-Lactamase Bacteria in a Neonatal Intensive Care Unit.
Pediatr Infect Dis J 2008 Feb;(): [Epub ahead of print]
First Outbreak of Multidrug-Resistant Klebsiella pneumoniae Producing both SHV-12-Type Extended-Spectrum beta-Lactamase and DHA-1-Type AmpC beta-Lactamase at a Korean Hospital.
Yonsei Med J 2008 Feb;49(1):53-7
Redefining the management of pediatric tonsillopharyngitis with cefprozil.
Indian J Pediatr 2007 Dec;74(12):1105-8
[Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci.]
Rev Esp Quimioter 2007 Sep;20(3):317-22